Skip to main content
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1987 Feb;71(2):102–106. doi: 10.1136/bjo.71.2.102

Rational acyclovir therapy in herpetic eye disease.

M G Falcon
PMCID: PMC1041098  PMID: 3548806

Abstract

Acyclovir has been widely used against the various manifestations of eye disease due to herpes simplex since it first became generally available in the UK nearly five years ago. This paper discusses the rational indications for its use, through considerations of its pharmacology and pharmacokinetics, and through results of the many clinical trials that have been carried out to investigate its effects since its clinical efficacy was first demonstrated in 1979.

Full text

PDF
102

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bauer D. J., Collins P., Tucker W. E., Jr, Macklin A. W. Treatment of experimental herpes simplex keratitis with acycloguanosine. Br J Ophthalmol. 1979 Jun;63(6):429–435. doi: 10.1136/bjo.63.6.429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Blyth W. A., Harbour D. A., Hill T. J. Effect of acyclovir on recurrence of herpes simplex skin lesions in mice. J Gen Virol. 1980 Jun;48(Pt 2):417–419. doi: 10.1099/0022-1317-48-2-417. [DOI] [PubMed] [Google Scholar]
  3. Cobo L. M., Coster D. J., Rice N. S., Jones B. R. Prognosis and management of corneal transplantation for herpetic keratitis. Arch Ophthalmol. 1980 Oct;98(10):1755–1759. doi: 10.1001/archopht.1980.01020040607002. [DOI] [PubMed] [Google Scholar]
  4. Colin J., Chastel C., Renard G., Cantell K. Combination therapy for dendritic keratitis with human leukocyte interferon and acyclovir. Am J Ophthalmol. 1983 Mar;95(3):346–348. doi: 10.1016/s0002-9394(14)78303-5. [DOI] [PubMed] [Google Scholar]
  5. Collum L. M., Akhtar J., McGettrick P. Oral acyclovir in herpetic keratitis. Trans Ophthalmol Soc U K. 1985;104(Pt 6):629–632. [PubMed] [Google Scholar]
  6. Collum L. M., Logan P., McAuliffe-Curtin D., Hung S. O., Patterson A., Rees P. J. Randomised double-blind trial of acyclovir (Zovirax) and adenine arabinoside in herpes simplex amoeboid corneal ulceration. Br J Ophthalmol. 1985 Nov;69(11):847–850. doi: 10.1136/bjo.69.11.847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Collum L. M., Logan P., Ravenscroft T. Acyclovir (Zovirax) in herpetic disciform keratitis. Br J Ophthalmol. 1983 Feb;67(2):115–118. doi: 10.1136/bjo.67.2.115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Coster D. J., Jones B. R., McGill J. I. Treatment of amoeboid herpetic ulcers with adenine arabinoside or trifluorothymidine. Br J Ophthalmol. 1979 Jun;63(6):418–421. doi: 10.1136/bjo.63.6.418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Coster D. J., Welham R. A. Herpetic canalicular obstruction. Br J Ophthalmol. 1979 Apr;63(4):259–262. doi: 10.1136/bjo.63.4.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Coster D. J., Wilhelmus K. R., Michaud R., Jones B. R. A comparison of acyclovir and idoxuridine as treatment for ulcerative herpetic keratitis. Br J Ophthalmol. 1980 Oct;64(10):763–765. doi: 10.1136/bjo.64.10.763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Culbertson W. W., Clarkson J. G., Blumenkranz M., Lewis M. L. Acute retinal necrosis. Am J Ophthalmol. 1983 Nov;96(5):683–685. doi: 10.1016/s0002-9394(14)73430-0. [DOI] [PubMed] [Google Scholar]
  12. Darougar S., Wishart M. S., Viswalingam N. D. Epidemiological and clinical features of primary herpes simplex virus ocular infection. Br J Ophthalmol. 1985 Jan;69(1):2–6. doi: 10.1136/bjo.69.1.2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Elion G. B., Furman P. A., Fyfe J. A., de Miranda P., Beauchamp L., Schaeffer H. J. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5716–5720. doi: 10.1073/pnas.74.12.5716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gordon Y. J., Araullo-Cruz T. Herpesvirus inoculation of cornea. Am J Ophthalmol. 1984 Apr;97(4):482–487. doi: 10.1016/s0002-9394(14)76132-x. [DOI] [PubMed] [Google Scholar]
  15. Gordon Y. J., Armstrong J. A., Brown S. I., Becker Y. The role of herpesvirus type 1 thymidine kinase in experimental ocular infections. Am J Ophthalmol. 1983 Feb;95(2):175–181. doi: 10.1016/0002-9394(83)90011-9. [DOI] [PubMed] [Google Scholar]
  16. Grutzmacher R. D., Henderson D., McDonald P. J., Coster D. J. Herpes simplex chorioretinitis in a healthy adult. Am J Ophthalmol. 1983 Dec;96(6):788–796. doi: 10.1016/s0002-9394(14)71925-7. [DOI] [PubMed] [Google Scholar]
  17. Howe J. W., Narang H. K., Codd A. A. Herpes simplex virus uveitis and optic neuropathy. An experimental investigation. Trans Ophthalmol Soc U K. 1979 Apr;99(1):111–116. [PubMed] [Google Scholar]
  18. Hung S. O., Patterson A., Rees P. J. Pharmacokinetics of oral acyclovir (Zovirax) in the eye. Br J Ophthalmol. 1984 Mar;68(3):192–195. doi: 10.1136/bjo.68.3.192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Jones B. R., Coster D. J., Fison P. N., Thompson G. M., Cobo L. M., Falcon M. G. Efficacy of acycloguanosine (Wellcome 248U) against herpes-simplex corneal ulcers. Lancet. 1979 Feb 3;1(8110):243–244. doi: 10.1016/s0140-6736(79)90769-4. [DOI] [PubMed] [Google Scholar]
  20. Jones B. R., Falcon M. G., Williams H. P., Coster D. J. Objectives in therapy of herpetic eye disease. Trans Ophthalmol Soc U K. 1977 Jul;97(2):305–313. [PubMed] [Google Scholar]
  21. Kaufman H. E. Antimetabolite drug therapy in herpes simplex. Ophthalmology. 1980 Feb;87(2):135–139. doi: 10.1016/s0161-6420(80)35273-1. [DOI] [PubMed] [Google Scholar]
  22. Kaufman H. E., Varnell E. D., Centifanto Y. M., Kissling G. E. Effect of the herpes simplex virus genome on the response of infection to corticosteroids. Am J Ophthalmol. 1985 Jul 15;100(1):114–118. doi: 10.1016/s0002-9394(14)74992-x. [DOI] [PubMed] [Google Scholar]
  23. Mason E. O., Jr, Kaplan S. L., Baker C. J., Ritter D. A. Modification of the colorimetric assay for chloramphenicol in the presence of bilirubin. Antimicrob Agents Chemother. 1979 Apr;15(4):544–546. doi: 10.1128/aac.15.4.544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Maudgal P. C., De Clercq K., Descamps J., Missotten L. Topical treatment of experimental herpes simplex keratouveitis with 2'-O-glycylacyclovir. A water-soluble ester of acyclovir. Arch Ophthalmol. 1984 Jan;102(1):140–142. doi: 10.1001/archopht.1984.01040030118049. [DOI] [PubMed] [Google Scholar]
  25. Maudgal P. C., Vrijghem J. C., Molemans M., Missotten L. Effect of topical acyclovir therapy on experimental herpes simplex keratouveitis. Arch Ophthalmol. 1985 Sep;103(9):1389–1392. doi: 10.1001/archopht.1985.01050090141050. [DOI] [PubMed] [Google Scholar]
  26. Mitchell C. D., Bean B., Gentry S. R., Groth K. E., Boen J. R., Balfour H. H., Jr Acyclovir therapy for mucocutaneous herpes simplex infections in immunocompromised patients. Lancet. 1981 Jun 27;1(8235):1389–1392. doi: 10.1016/s0140-6736(81)92569-1. [DOI] [PubMed] [Google Scholar]
  27. Nahmias A. J., Visintine A. M., Caldwell D. R., Wilson L. A. Eye infections with herpes simplex viruses in neonates. Surv Ophthalmol. 1976 Sep-Oct;21(2):100–105. doi: 10.1016/0039-6257(76)90086-2. [DOI] [PubMed] [Google Scholar]
  28. Oh J. O. Primary and secondary herpes simplex uveitis in rabbits. Surv Ophthalmol. 1976 Sep-Oct;21(2):178–184. doi: 10.1016/0039-6257(76)90097-7. [DOI] [PubMed] [Google Scholar]
  29. Patterson A., Jones B. R. The management of ocular herpes. Trans Ophthalmol Soc U K. 1967;87:59–84. [PubMed] [Google Scholar]
  30. Poirier R. H., Kingham J. D., de Miranda P., Annel M. Intraocular antiviral penetration. Arch Ophthalmol. 1982 Dec;100(12):1964–1967. doi: 10.1001/archopht.1982.01030040944016. [DOI] [PubMed] [Google Scholar]
  31. Pulido J., Peyman G. A., Lesar T., Vernot J. Intravitreal toxicity of hydroxyacyclovir (BW-B759U), a new antiviral agent. Arch Ophthalmol. 1985 Jun;103(6):840–841. doi: 10.1001/archopht.1985.01050060100036. [DOI] [PubMed] [Google Scholar]
  32. Sanitato J. J., Asbell P. A., Varnell E. D., Kissling G. E., Kaufman H. E. Acyclovir in the treatment of herpetic stromal disease. Am J Ophthalmol. 1984 Nov;98(5):537–547. doi: 10.1016/0002-9394(84)90237-x. [DOI] [PubMed] [Google Scholar]
  33. Sarkies N., Gregor Z., Forsey T., Darougar S. Antibodies to herpes simplex virus type I in intraocular fluids of patients with acute retinal necrosis. Br J Ophthalmol. 1986 Feb;70(2):81–84. doi: 10.1136/bjo.70.2.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Schaeffer H. J., Beauchamp L., de Miranda P., Elion G. B., Bauer D. J., Collins P. 9-(2-hydroxyethoxymethyl) guanine activity against viruses of the herpes group. Nature. 1978 Apr 13;272(5654):583–585. doi: 10.1038/272583a0. [DOI] [PubMed] [Google Scholar]
  35. Shimeld C., Tullo A. B., Easty D. L., Thomsitt J. Isolation of herpes simplex virus from the cornea in chronic stromal keratitis. Br J Ophthalmol. 1982 Oct;66(10):643–647. doi: 10.1136/bjo.66.10.643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Sköldenberg B., Forsgren M., Alestig K., Bergström T., Burman L., Dahlqvist E., Forkman A., Frydén A., Lövgren K., Norlin K. Acyclovir versus vidarabine in herpes simplex encephalitis. Randomised multicentre study in consecutive Swedish patients. Lancet. 1984 Sep 29;2(8405):707–711. doi: 10.1016/s0140-6736(84)92623-0. [DOI] [PubMed] [Google Scholar]
  37. Sundmacher R. Orale Acyclovir-Therapie virologisch nachgewiesener intraokularer Herpes simplex Virus Infektionen. Klin Monbl Augenheilkd. 1983 Oct;183(4):246–250. doi: 10.1055/s-2008-1054912. [DOI] [PubMed] [Google Scholar]
  38. Tullo A. B., Easty D. L., Hill T. J., Blyth W. A. Ocular herpes simplex and the establishment of latent infection. Trans Ophthalmol Soc U K. 1982 Apr;102(Pt 1):15–18. [PubMed] [Google Scholar]
  39. Wilhelmus K. R., Falcon M. G., Jones B. R. Herpetic iridocyclitis. Int Ophthalmol. 1982 Feb;4(3):143–150. doi: 10.1007/BF00161904. [DOI] [PubMed] [Google Scholar]
  40. Williams H. P., Falcon M. G., Jones B. R. Corticosteroids in the management of herpetic eye disease. Trans Ophthalmol Soc U K. 1977 Jul;97(2):341–344. [PubMed] [Google Scholar]
  41. de Koning E. W., van Bijsterveld O. P., Cantell K. Combination therapy for dendritic keratitis with acyclovir and alpha-interferon. Arch Ophthalmol. 1983 Dec;101(12):1866–1868. doi: 10.1001/archopht.1983.01040020868006. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES